Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial

Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people each year. Early intracranial bleeding is common after TBI, increasing the risk of death and disability. Tranexamic acid reduces blood loss in surgery and death due to bleeding in trauma patients with ex...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Wellcome Open Res
Główni autorzy: Roberts, Ian, Belli, Antonio, Brenner, Amy, Chaudhri, Rizwana, Fawole, Bukola, Harris, Tim, Jooma, Rashid, Mahmood, Abda, Shokunbi, Temitayo, Shakur, Haleema
Format: Artigo
Język:Inglês
Wydane: F1000 Research Limited 2018
Hasła przedmiotowe:
Method Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081978/
https://ncbi.nlm.nih.gov/pubmed/30175246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.14700.2
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy